neurofibromatosis type 2 Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (2)

Interventional (2)

Scott R. Plotkin, MD, PhD (1)
University of Alabama at Birmingham (1)

No (2)

No (2)

Adult (18+) (2)
Pediatric (Under 18) (2)

I am/have/had

I am/have/hadconventional imaging

I am/have/hadneurofibroma

I am/have/hadexperimental therapy

I am/have/hadmeningiomatosis

I am/have/hadcataract

I am/have/hadneutrophil count

I am/have/hadbilateral tubal ligation

I am/have/hadconventional mri

I am/have/hadmultiple meningiomas

I am/have/hadneurofibromatosis type 2

I am/have/hadnf2 gene

I am/have/hadacoustic neuroma

I am/have/hadvasectomy

I am/have/hadintrauterine device (iud)

I am/have/hadmeasurable disease

I am/have/hadinvestigational therapy

I am/have/hadglioma

I am/have/hadmeningioma

I am/have/hadkarnofsky performance status

I am/have/hadschwartz

added new label for I am/have/had

more

I am looking for

I am looking forcrizotinib

I am looking forbrigatinib

I am looking forinvestigational drug

I am looking forexperimental drug

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For pediatric ages
For Seniors
Recruiting in 10s
Interventional Study
all
Genetic Disease
Recruiting

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Subjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, for a maximum of 12 cycles.

neurofibroma

crizotinib

cataract

glioma

neutrophil count

0 views
19 Feb, 2024

Phase 2
For pediatric ages
For Seniors
Recruiting in 10s
Interventional Study
all
Neurology
Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2

This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated progressive tumors of vestibular schwannomas (VS), non-vestibular schwannomas (non-VS), meningiomas, and ependymomas.

conventional imaging

neurofibroma

experimental therapy

meningiomatosis

cataract

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.